This action disrupts DSG2-mediated desmosome junctions and weakens cell adhesion, thereby inhibiting the formation of CTC clusters in breast tumor cells and reducing lung metastasis (Fig. 9). The gene discussed is DSG2; the disease is breast neoplasm.